Latest Ratios: P/E Ratio 22.6x · EV/EBITDA 12.4x · ROE 14.4%. (2020–2025 historical series)
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|---|
| Market Cap | $33.0B | $33.1B | $41.4B | $41.2B | — | — | — |
| Enterprise Value | $40.5B | $40.5B | $49.1B | $48.3B | — | — | — |
| P/E Ratio → | 22.63 | 22.62 | 39.87 | 24.75 | — | — | — |
| P/S Ratio | 2.18 | 2.19 | 2.68 | 2.67 | — | — | — |
| P/B Ratio | 3.07 | 3.07 | 4.28 | 3.68 | — | — | — |
| P/FCF | 19.18 | 19.21 | 31.01 | 15.28 | — | — | — |
| P/OCF | 15.03 | 15.05 | 23.40 | 13.01 | — | — | — |
P/E links to full P/E history page with 30-year chart
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 2.68 | 3.17 | 3.13 | — | — | — |
| EV / EBITDA | 12.42 | 12.43 | 19.92 | 15.38 | — | — | — |
| EV / EBIT | 14.97 | 17.05 | 26.57 | 18.95 | — | — | — |
| EV / FCF | — | 23.54 | 36.74 | 17.89 | — | — | — |
Margins and return-on-capital ratios measuring operating efficiency
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|---|
| Gross Margin | 58.1% | 58.1% | 58.0% | 56.0% | 55.4% | 55.9% | 54.2% |
| Operating Margin | 17.9% | 17.9% | 11.9% | 16.3% | 17.9% | 19.4% | -6.8% |
| Net Profit Margin | 9.7% | 9.7% | 6.7% | 10.8% | 13.8% | 13.8% | -6.1% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|---|
| ROE | 14.4% | 14.4% | 9.9% | 10.7% | 10.2% | 10.7% | -4.8% |
| ROA | 5.6% | 5.6% | 3.9% | 6.0% | 7.5% | 7.3% | -3.0% |
| ROIC | 11.4% | 11.4% | 7.8% | 8.2% | 8.4% | 11.7% | -4.1% |
| ROCE | 13.2% | 13.2% | 8.7% | 11.0% | 11.3% | 12.8% | -4.5% |
Solvency and debt-coverage ratios — lower is generally safer
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.79 | 0.79 | 0.90 | 0.75 | 0.45 | 0.01 | — |
| Debt / EBITDA | 2.61 | 2.61 | 3.54 | 2.68 | 2.73 | 0.04 | — |
| Net Debt / Equity | — | 0.69 | 0.79 | 0.63 | 0.39 | -0.03 | -0.03 |
| Net Debt / EBITDA | 2.29 | 2.29 | 3.11 | 2.24 | 2.35 | -0.17 | — |
| Debt / FCF | — | 4.33 | 5.73 | 2.61 | 3.63 | -15.67 | -0.20 |
| Interest Coverage | 6.27 | 6.27 | 4.28 | 7.12 | — | — | — |
Short-term solvency ratios and asset-utilisation metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 0.96 | 0.96 | 0.96 | 1.12 | 1.50 | 1.22 | 0.61 |
| Quick Ratio | 0.68 | 0.68 | 0.69 | 0.78 | 0.93 | 0.80 | 0.39 |
| Cash Ratio | 0.18 | 0.18 | 0.19 | 0.25 | 0.31 | 0.18 | 0.08 |
| Asset Turnover | — | 0.56 | 0.60 | 0.55 | 0.55 | 0.54 | 0.50 |
| Inventory Turnover | 3.80 | 3.80 | 4.08 | 3.67 | 2.99 | 3.90 | 3.93 |
| Days Sales Outstanding | — | 67.91 | 62.80 | 62.39 | 56.08 | 56.52 | 53.74 |
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|---|
| Dividend Yield | 4.8% | 4.8% | 3.7% | 35.3% | — | — | — |
| Payout Ratio | 107.6% | 107.6% | 150.7% | 874.6% | — | — | — |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|---|
| Earnings Yield | 4.4% | 4.4% | 2.5% | 4.0% | — | — | — |
| FCF Yield | 5.2% | 5.2% | 3.2% | 6.5% | — | — | — |
| Buyback Yield | 0.6% | 0.6% | 0.6% | 0.0% | — | — | — |
| Total Shareholder Yield | 5.4% | 5.4% | 4.3% | 35.3% | — | — | — |
| Shares Outstanding | — | $1.9B | $1.9B | $1.9B | $1.9B | $1.9B | $1.9B |
Includes 30+ ratios · 6 years · Updated daily
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying KVUE stock.
Kenvue Inc.'s current P/E ratio is 22.6x. The historical average is 29.1x. This places it at the 33th percentile of its historical range.
Kenvue Inc.'s current EV/EBITDA is 12.4x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 15.9x.
Kenvue Inc.'s return on equity (ROE) is 14.4%. The historical average is 8.5%.
Based on historical data, Kenvue Inc. is trading at a P/E of 22.6x. This is at the 33th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.
Kenvue Inc.'s current dividend yield is 4.78% with a payout ratio of 107.6%.
Kenvue Inc. has 58.1% gross margin and 17.9% operating margin. Operating margin between 10-20% is typical for established companies.
Kenvue Inc.'s Debt/EBITDA ratio is 2.6x, indicating moderate leverage. A ratio between 2-4x is manageable but warrants monitoring.
Key Metrics
Top Statement Risk
Skin Health volume pressure
Metrics are mathematically derived from official filings.
Margin Recovery Masks Underlying Pressures
Operating margin expanded from 3.9% in Q2 2024 to 17.7% in Q2 2026, per reported figures, yet gross margin dipped to 58.2%, suggesting cost discipline is driving recovery rather than pricing power.
The operating margin recovery is largely attributable to the fading of separation-related costs and improved SG&A leverage, as gross margin has remained range-bound near 58-59%. However, the recent dip in gross margin from 59.1% in Q3 2025 to 58.2% in Q2 2026 may indicate input cost pressures or promotional activity. Net margin of 11.5% in Q2 2026 remains below the 12.1% seen in Q1 2026, reflecting ongoing volatility in non-operating items. Investors should monitor whether the operating margin can sustain above 17% as the company fully absorbs standalone costs.
Return on Capital Remains Subdued
ROIC has hovered between 2.0% and 3.5% over the past ten quarters, per company filings, well below the cost of capital, indicating limited value creation from invested capital.
Despite margin recovery, ROIC remains low, reflecting a high capital base driven by $9.3B in goodwill and intangibles from the spin-off. ROE has also been weak, ranging from 0.6% to 4.4%, with the Q2 2024 trough of 0.6% coinciding with separation costs. The asset turnover of 0.14-0.15 is stable but low, typical for consumer staples, yet the returns are insufficient to cover the cost of capital. This suggests that the company is not yet compounding returns, and any improvement will likely require either margin expansion or a reduction in the capital base through buybacks or impairments.
Working Capital Efficiency Shows Modest Gains
Cash conversion cycle improved from 37 days in Q4 2024 to 20 days in Q2 2026, per reported data, driven by a reduction in days inventory outstanding from 100 to 93.
The improvement in CCC is primarily due to better inventory management, as DIO fell from 106 days in Q3 2025 to 93 days in Q2 2026, while DSO remained stable near 67 days. DPO has been consistently high, around 140 days, indicating strong supplier leverage, though this may reflect extended payment terms that could strain supplier relationships. The quick ratio of 0.71 remains low, but the negative working capital position is common in consumer staples with high DPO. The efficiency gains are modest and may not be sustainable if inventory levels need to be rebuilt to support growth.
Leverage Elevated but Coverage Improving
Debt-to-EBITDA has declined from 29.17 in Q2 2024 to 10.05 in Q2 2026, per financial statements, while interest coverage improved from 1.61 to 7.64, indicating reduced refinancing risk.
The dramatic improvement in D/EBITDA reflects both EBITDA growth and debt reduction, though the ratio remains high relative to peers like PG (0.63) and CHD (0.55). Interest coverage of 7.64 is now comfortable, but the absolute debt level of $8.5B is substantial for a company with $10.6B in equity. The D/E ratio of 0.80 is manageable, but the company's ability to deleverage further will depend on sustained FCF generation. The cessation of buybacks and a dividend payout ratio exceeding 100% of net income suggest that cash is being prioritized for debt reduction, which is prudent but limits shareholder returns.
Thin Liquidity Buffer Persists
Current ratio has remained near 1.0 over the past ten quarters, with cash flat at $1.1B, per balance sheet data, providing a minimal cushion against short-term obligations.
The current ratio of 1.01 in Q2 2026 is barely above 1.0, and the quick ratio of 0.71 indicates heavy reliance on inventory to meet short-term liabilities. This thin liquidity position is typical for consumer staples with strong supplier financing, but it leaves little room for unexpected cash outflows. The company's ability to weather a demand shock would depend on its access to credit markets, which is not directly observable from the data. Investors should monitor whether the company can maintain its dividend while continuing to deleverage, as the payout ratio already exceeds 100% of net income.
Misapplied Metric: EV/EBITDA
EV/EBITDA of 13.59 appears reasonable, but it understates leverage because EBITDA does not capture the high cash interest costs and the company's thin liquidity, per reported figures.
For a company with significant debt and a low current ratio, EV/EBITDA can be misleading because it ignores the capital structure's risk. A more appropriate metric would be EV/EBIT or EV/EBITDAR, which accounts for the high depreciation and amortization from the spin-off's step-up in asset values. Additionally, the company's FCF yield of 4.7% (based on P/FCF of 21.41) is more informative, as it reflects actual cash generation after capex. Investors should also consider the dividend payout ratio, which exceeds 100% of net income, indicating that the dividend may not be fully covered by earnings.